These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 819217)

  • 1. Double-blind comparison of cephradine and cephalexin in the treatment of skin and soft-tissue infections due to Staphylococcus aureus.
    Hubsher JA; Gadebusch HH; Itkin AG
    Curr Ther Res Clin Exp; 1976 Jun; 19(6):579-88. PubMed ID: 819217
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative efficacy and safety of cephradine and cephalexin in children.
    Mouallem R
    J Int Med Res; 1976; 4(4):265-71. PubMed ID: 799997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cephradine and cephalexin in the treatment of children with bacterial pneumonia.
    Alban J; Caloza DL
    Curr Ther Res Clin Exp; 1975 Oct; 18(4):539-45. PubMed ID: 241608
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of cepharadine and cephalexin in the treatment of respiratory and urinary tract infections.
    Mogabgab WJ
    Curr Ther Res Clin Exp; 1976 Apr; 19(4):421-32. PubMed ID: 4284
    [No Abstract]   [Full Text] [Related]  

  • 5. Biophotometric investigations on the influence of cephradine and related cephalosporins on the growth of beta-lactamase-producing staphylococi.
    Breuer A; Starke B
    Arzneimittelforschung; 1978; 28(8):1327-30. PubMed ID: 313798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of cephalexin in the treatment of skin and soft-tissue infections.
    Derrick CW; Reilly K
    Postgrad Med J; 1983; 59 Suppl 5():43-6. PubMed ID: 6364089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cefdinir vs. cephalexin for mild to moderate uncomplicated skin and skin structure infections in adolescents and adults.
    Giordano PA; Elston D; Akinlade BK; Weber K; Notario GF; Busman TA; Cifaldi M; Nilius AM
    Curr Med Res Opin; 2006 Dec; 22(12):2419-28. PubMed ID: 17257456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibiotic resistance trends of Staphylococcus pyogenes--a 4 year rural and urban survey report.
    Aggarwal P; Ichhpujani RL; Anand BR; Rai Chowdhuri AN
    J Commun Dis; 1982 Mar; 14(1):78-81. PubMed ID: 7142684
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical evaluation of cephradine, a new oral cephalosporin.
    Scholand JF; Hodges GR; Fass RJ; Saslaw S
    Am J Med Sci; 1974 Feb; 267(2):111-6. PubMed ID: 4595266
    [No Abstract]   [Full Text] [Related]  

  • 10. Activity of cefroxadine and cephalexin in urinary tract infections: a double-blind comparative study.
    Ahrens T; Naber KG
    Infection; 1983; 11(1):25-30. PubMed ID: 6341252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ofloxacin versus cephalexin in the treatment of skin, skin structure, and soft-tissue infections in adults.
    Powers RD; Schwartz R; Snow RM; Yarbrough DR
    Clin Ther; 1991; 13(6):727-36. PubMed ID: 1790547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and laboratory studies with cefaclor: efficacy in skin and soft tissue infections.
    Dillon HC; Gray BM; Ware JC
    Postgrad Med J; 1979; 55 Suppl 4():77-81. PubMed ID: 548944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical experience with cephradine].
    Ughy E
    MMW Munch Med Wochenschr; 1977 Aug; 119(34):1093-4. PubMed ID: 408658
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical evaluation of cefpodoxime proxetil in the treatment of skin and soft tissue infections. A double blind comparison of cefpodoxime proxetil and cefaclor].
    Yura J; Shinagawa N; Mizuno A; Watanabe S; Ando M; Sakai K; Ueda T; Morimoto K; Nakamura T; Hashimoto I
    Jpn J Antibiot; 1988 Oct; 41(10):1517-37. PubMed ID: 3060626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Moxifloxacin versus cephalexin in the treatment of uncomplicated skin infections.
    Parish LC; Routh HB; Miskin B; Fidelholtz J; Werschler P; Heyd A; Haverstock D; Church D
    Int J Clin Pract; 2000 Oct; 54(8):497-503. PubMed ID: 11198726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A simplified regimen for treatment of skin and soft tissue infections.
    Caloza DL; Losi MJ; Ackerman HJ
    Cutis; 1980 Feb; 25(2):222-4. PubMed ID: 6987042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical trials of cefroxadine on skin and soft tissue infections in the field of pediatrics (author's transl)].
    Motohiro T; Tanaka K; Koga T; Shimada Y; Tomita N; Sakata Y; Nishiyama T; Fujimoto T; Nakajima T; Ishimoto K; Tominaga K; Yamashita F; Tomoishi T; Takenaka S; Kamezaki K; Ohyama K; Takasaki K; Oki S; Yoshinaga Y; Nagai T; Kawano N; Toyoda J; Shimohida T
    Jpn J Antibiot; 1981 Dec; 34(12):1732-46. PubMed ID: 7038190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of cephradine and cephalothin in the treatment of urinary tract infections.
    Caloza DL; Losi MJ; Fields LA
    N C Med J; 1977 Oct; 38(10):597-600. PubMed ID: 335255
    [No Abstract]   [Full Text] [Related]  

  • 19. [Double-blind comparative trial of cefroxadine and cephalexin in the treatment of acute suppurative otitis media and acute exacerbation of chronic suppurative otitis media].
    Baba S; Murai K; Kinoshita H; Kawai T; Koyama K; Tsukiyama M; Maruo T; Wada K; Inagaki M; Matsushita T
    Jpn J Antibiot; 1983 Sep; 36(9):2595-634. PubMed ID: 6361325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Case study and panel discussion.
    Maki DG; Ebert SC; Rybak MJ
    Pharmacotherapy; 2007 Oct; 27(10 Pt 2):136S-143S. PubMed ID: 17896907
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.